# Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

> **NCT05121766** · PHASE1 · TERMINATED · sponsor: **Hackensack Meridian Health** · enrollment: 32 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Omega-3 (EPA+DHA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05121766
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-10
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-04-21
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Challenges in enrollment
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121766, "Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05121766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*